Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000335667 | SCV000354917 | benign | Lethal Kniest-like syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000394536 | SCV000354918 | benign | Schwartz-Jampel syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Athena Diagnostics Inc | RCV000518718 | SCV000613721 | benign | not specified | 2017-03-01 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000757385 | SCV000885586 | likely benign | not provided | 2017-12-31 | criteria provided, single submitter | clinical testing | The c.4132G>A; p.Glu1378Lys variant (rs62642525), to our knowledge, is not reported in the medical literature, but is listed in ClinVar as benign/uncertain significance (ClinVar ID 295849). This variant is listed in the genome Aggregation Database (gnomAD) with an African population frequency of 1.4% (identified on 242 out of 17,178 chromosomes, including 2 homozygotes). The glutamic acid at position 1378 is weakly conserved, considering 12 species (Alamut software v.2.10.0), and computational analyses of the effects of the p.Glu1378Lys variant on protein structure and function do not predict deleterious changes (SIFT: tolerated, PolyPhen-2: benign, Align GVGD: Class C0). Based on the available information, the p.Glu1378Lys variant is likely to be benign. |
Invitae | RCV000757385 | SCV001117301 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003910079 | SCV004721051 | benign | HSPG2-related condition | 2024-01-05 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |